You are here

  • Home
  • Archive
  • Volume 82, Issue 1
  • Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial

Article metrics

Article menu
Paediatric rheumatology
Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial

 

Online download statistics by month:

Online download statistics by month: August 2022 to March 2024

AbstractFullPdf
Aug 202212301246470
Sep 202210591051256
Oct 2022733729193
Nov 2022317309163
Dec 2022307305130
Jan 2023662640264
Feb 2023336327199
Mar 2023488470239
Apr 2023320308160
May 2023334328152
Jun 2023309298131
Jul 2023294278117
Aug 2023232216110
Sep 2023206186122
Oct 2023255220145
Nov 2023279256167
Dec 2023305276172
Jan 2024255222162
Feb 2024285276138
Mar 2024284264180
Total849082053670